nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—ADRA2A—epilepsy syndrome	0.184	1	CbGaD
Phenoxybenzamine—Phenylbutazone—Fosphenytoin—epilepsy syndrome	0.0631	0.152	CrCrCtD
Phenoxybenzamine—Phenylbutazone—Phenytoin—epilepsy syndrome	0.0432	0.104	CrCrCtD
Phenoxybenzamine—Modafinil—Fosphenytoin—epilepsy syndrome	0.0387	0.0933	CrCrCtD
Phenoxybenzamine—Antazoline—Phenytoin—epilepsy syndrome	0.0358	0.0864	CrCrCtD
Phenoxybenzamine—Phenylbutazone—Clobazam—epilepsy syndrome	0.0352	0.0849	CrCrCtD
Phenoxybenzamine—SLC22A1—Midazolam—epilepsy syndrome	0.0332	0.192	CbGbCtD
Phenoxybenzamine—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0269	0.065	CrCrCtD
Phenoxybenzamine—Modafinil—Phenytoin—epilepsy syndrome	0.0265	0.0639	CrCrCtD
Phenoxybenzamine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.025	0.0604	CrCrCtD
Phenoxybenzamine—Modafinil—Carbamazepine—epilepsy syndrome	0.0245	0.059	CrCrCtD
Phenoxybenzamine—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0225	0.0543	CrCrCtD
Phenoxybenzamine—Benzphetamine—Phenytoin—epilepsy syndrome	0.0199	0.048	CrCrCtD
Phenoxybenzamine—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0185	0.0445	CrCrCtD
Phenoxybenzamine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0177	0.0427	CrCrCtD
Phenoxybenzamine—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.017	0.0411	CrCrCtD
Phenoxybenzamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0123	0.071	CbGbCtD
Phenoxybenzamine—CYP3A4—Trimethadione—epilepsy syndrome	0.0114	0.066	CbGbCtD
Phenoxybenzamine—CYP3A4—Felbamate—epilepsy syndrome	0.0114	0.066	CbGbCtD
Phenoxybenzamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0108	0.0621	CbGbCtD
Phenoxybenzamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00973	0.0561	CbGbCtD
Phenoxybenzamine—CYP3A4—Clobazam—epilepsy syndrome	0.00933	0.0538	CbGbCtD
Phenoxybenzamine—CYP3A4—Rufinamide—epilepsy syndrome	0.00793	0.0458	CbGbCtD
Phenoxybenzamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00773	0.0446	CbGbCtD
Phenoxybenzamine—CYP3A4—Primidone—epilepsy syndrome	0.00722	0.0416	CbGbCtD
Phenoxybenzamine—CYP3A4—Phenytoin—epilepsy syndrome	0.00693	0.04	CbGbCtD
Phenoxybenzamine—CYP3A4—Propofol—epilepsy syndrome	0.00646	0.0373	CbGbCtD
Phenoxybenzamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00618	0.0357	CbGbCtD
Phenoxybenzamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00618	0.0357	CbGbCtD
Phenoxybenzamine—CYP3A4—Midazolam—epilepsy syndrome	0.00609	0.0352	CbGbCtD
Phenoxybenzamine—CYP3A4—Diazepam—epilepsy syndrome	0.00586	0.0338	CbGbCtD
Phenoxybenzamine—CYP3A4—Zonisamide—epilepsy syndrome	0.00572	0.033	CbGbCtD
Phenoxybenzamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00462	0.0266	CbGbCtD
Phenoxybenzamine—CYP3A4—Topiramate—epilepsy syndrome	0.00417	0.024	CbGbCtD
Phenoxybenzamine—Miosis—Midazolam—epilepsy syndrome	0.00315	0.0465	CcSEcCtD
Phenoxybenzamine—Miosis—Felbamate—epilepsy syndrome	0.00279	0.0412	CcSEcCtD
Phenoxybenzamine—Gastrointestinal tract irritation—Valproic Acid—epilepsy syndrome	0.00224	0.0331	CcSEcCtD
Phenoxybenzamine—CALM2—pons—epilepsy syndrome	0.00192	0.052	CbGeAlD
Phenoxybenzamine—CALM1—pons—epilepsy syndrome	0.00191	0.0517	CbGeAlD
Phenoxybenzamine—CALM1—autonomic nervous system—epilepsy syndrome	0.00176	0.0477	CbGeAlD
Phenoxybenzamine—Miosis—Pregabalin—epilepsy syndrome	0.00173	0.0256	CcSEcCtD
Phenoxybenzamine—Miosis—Gabapentin—epilepsy syndrome	0.00159	0.0234	CcSEcCtD
Phenoxybenzamine—CALM2—ear—epilepsy syndrome	0.00158	0.0428	CbGeAlD
Phenoxybenzamine—CALM1—ear—epilepsy syndrome	0.00157	0.0426	CbGeAlD
Phenoxybenzamine—Drowsiness—Primidone—epilepsy syndrome	0.0013	0.0192	CcSEcCtD
Phenoxybenzamine—SLC22A1—ganglion—epilepsy syndrome	0.00121	0.0328	CbGeAlD
Phenoxybenzamine—Drowsiness—Trimethadione—epilepsy syndrome	0.00115	0.0169	CcSEcCtD
Phenoxybenzamine—SLC22A3—tongue—epilepsy syndrome	0.00114	0.031	CbGeAlD
Phenoxybenzamine—Nasal congestion—Levetiracetam—epilepsy syndrome	0.00103	0.0153	CcSEcCtD
Phenoxybenzamine—Drowsiness—Phenobarbital—epilepsy syndrome	0.00102	0.015	CcSEcCtD
Phenoxybenzamine—CALM2—ganglion—epilepsy syndrome	0.000981	0.0266	CbGeAlD
Phenoxybenzamine—CALM1—ganglion—epilepsy syndrome	0.000977	0.0265	CbGeAlD
Phenoxybenzamine—Nasal congestion—Vigabatrin—epilepsy syndrome	0.000973	0.0144	CcSEcCtD
Phenoxybenzamine—Drowsiness—Clobazam—epilepsy syndrome	0.000908	0.0134	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Fosphenytoin—epilepsy syndrome	0.000831	0.0123	CcSEcCtD
Phenoxybenzamine—Drowsiness—Acetazolamide—epilepsy syndrome	0.00081	0.012	CcSEcCtD
Phenoxybenzamine—Nasal congestion—Lamotrigine—epilepsy syndrome	0.000802	0.0118	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Diazepam—epilepsy syndrome	0.000797	0.0118	CcSEcCtD
Phenoxybenzamine—Somnolence—Amobarbital—epilepsy syndrome	0.000767	0.0113	CcSEcCtD
Phenoxybenzamine—CALM2—hindbrain—epilepsy syndrome	0.000744	0.0202	CbGeAlD
Phenoxybenzamine—CALM1—hindbrain—epilepsy syndrome	0.000741	0.0201	CbGeAlD
Phenoxybenzamine—Somnolence—Primidone—epilepsy syndrome	0.000739	0.0109	CcSEcCtD
Phenoxybenzamine—Drowsiness—Midazolam—epilepsy syndrome	0.000736	0.0109	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Vigabatrin—epilepsy syndrome	0.000735	0.0109	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Clonazepam—epilepsy syndrome	0.000728	0.0108	CcSEcCtD
Phenoxybenzamine—Drowsiness—Levetiracetam—epilepsy syndrome	0.000726	0.0107	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Phenytoin—epilepsy syndrome	0.000723	0.0107	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Oxcarbazepine—epilepsy syndrome	0.000719	0.0106	CcSEcCtD
Phenoxybenzamine—Fatigue—Primidone—epilepsy syndrome	0.000717	0.0106	CcSEcCtD
Phenoxybenzamine—ADRA1A—hindbrain—epilepsy syndrome	0.000698	0.0189	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Carbamazepine—epilepsy syndrome	0.00069	0.0102	CcSEcCtD
Phenoxybenzamine—Drowsiness—Vigabatrin—epilepsy syndrome	0.000683	0.0101	CcSEcCtD
Phenoxybenzamine—Drowsiness—Diazepam—epilepsy syndrome	0.000673	0.00994	CcSEcCtD
Phenoxybenzamine—ADRA1D—forebrain—epilepsy syndrome	0.000672	0.0182	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Lamotrigine—epilepsy syndrome	0.000667	0.00985	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Clonazepam—epilepsy syndrome	0.000661	0.00976	CcSEcCtD
Phenoxybenzamine—Somnolence—Trimethadione—epilepsy syndrome	0.00065	0.0096	CcSEcCtD
Phenoxybenzamine—Fatigue—Trimethadione—epilepsy syndrome	0.00063	0.00931	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Carbamazepine—epilepsy syndrome	0.000626	0.00925	CcSEcCtD
Phenoxybenzamine—ADRA1D—telencephalon—epilepsy syndrome	0.000618	0.0168	CbGeAlD
Phenoxybenzamine—Drowsiness—Clonazepam—epilepsy syndrome	0.000614	0.00907	CcSEcCtD
Phenoxybenzamine—Drowsiness—Phenytoin—epilepsy syndrome	0.00061	0.00901	CcSEcCtD
Phenoxybenzamine—Asthenia—Primidone—epilepsy syndrome	0.000596	0.00881	CcSEcCtD
Phenoxybenzamine—Drowsiness—Carbamazepine—epilepsy syndrome	0.000582	0.0086	CcSEcCtD
Phenoxybenzamine—Nasal congestion—Pregabalin—epilepsy syndrome	0.000576	0.00851	CcSEcCtD
Phenoxybenzamine—Somnolence—Phenobarbital—epilepsy syndrome	0.000576	0.0085	CcSEcCtD
Phenoxybenzamine—Somnolence—Rufinamide—epilepsy syndrome	0.000565	0.00835	CcSEcCtD
Phenoxybenzamine—Drowsiness—Lamotrigine—epilepsy syndrome	0.000563	0.00831	CcSEcCtD
Phenoxybenzamine—Fatigue—Rufinamide—epilepsy syndrome	0.000548	0.00809	CcSEcCtD
Phenoxybenzamine—Somnolence—Lacosamide—epilepsy syndrome	0.000531	0.00784	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Valproic Acid—epilepsy syndrome	0.00053	0.00783	CcSEcCtD
Phenoxybenzamine—Asthenia—Trimethadione—epilepsy syndrome	0.000525	0.00775	CcSEcCtD
Phenoxybenzamine—Somnolence—Clobazam—epilepsy syndrome	0.000515	0.00761	CcSEcCtD
Phenoxybenzamine—Fatigue—Lacosamide—epilepsy syndrome	0.000515	0.0076	CcSEcCtD
Phenoxybenzamine—SLC22A1—forebrain—epilepsy syndrome	0.000507	0.0138	CbGeAlD
Phenoxybenzamine—Fatigue—Clobazam—epilepsy syndrome	0.000499	0.00738	CcSEcCtD
Phenoxybenzamine—CALM3—telencephalon—epilepsy syndrome	0.000482	0.0131	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Valproic Acid—epilepsy syndrome	0.000481	0.0071	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Pregabalin—epilepsy syndrome	0.000479	0.00708	CcSEcCtD
Phenoxybenzamine—Tachycardia—Propofol—epilepsy syndrome	0.000468	0.00691	CcSEcCtD
Phenoxybenzamine—SLC22A1—telencephalon—epilepsy syndrome	0.000466	0.0127	CbGeAlD
Phenoxybenzamine—Somnolence—Acetazolamide—epilepsy syndrome	0.000459	0.00678	CcSEcCtD
Phenoxybenzamine—Tachycardia—Midazolam—epilepsy syndrome	0.000458	0.00676	CcSEcCtD
Phenoxybenzamine—Asthenia—Rufinamide—epilepsy syndrome	0.000456	0.00674	CcSEcCtD
Phenoxybenzamine—Drowsiness—Valproic Acid—epilepsy syndrome	0.000447	0.00661	CcSEcCtD
Phenoxybenzamine—Fatigue—Acetazolamide—epilepsy syndrome	0.000445	0.00657	CcSEcCtD
Phenoxybenzamine—Nasal congestion—Topiramate—epilepsy syndrome	0.000444	0.00656	CcSEcCtD
Phenoxybenzamine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000436	0.00645	CcSEcCtD
Phenoxybenzamine—Asthenia—Lacosamide—epilepsy syndrome	0.000428	0.00632	CcSEcCtD
Phenoxybenzamine—CALM2—brainstem—epilepsy syndrome	0.000427	0.0116	CbGeAlD
Phenoxybenzamine—Somnolence—Propofol—epilepsy syndrome	0.000426	0.0063	CcSEcCtD
Phenoxybenzamine—CALM1—brainstem—epilepsy syndrome	0.000425	0.0115	CbGeAlD
Phenoxybenzamine—Tachycardia—Diazepam—epilepsy syndrome	0.000419	0.00619	CcSEcCtD
Phenoxybenzamine—Somnolence—Midazolam—epilepsy syndrome	0.000417	0.00616	CcSEcCtD
Phenoxybenzamine—Asthenia—Clobazam—epilepsy syndrome	0.000416	0.00614	CcSEcCtD
Phenoxybenzamine—Fatigue—Propofol—epilepsy syndrome	0.000413	0.00611	CcSEcCtD
Phenoxybenzamine—Somnolence—Levetiracetam—epilepsy syndrome	0.000412	0.00608	CcSEcCtD
Phenoxybenzamine—CALM2—forebrain—epilepsy syndrome	0.000412	0.0112	CbGeAlD
Phenoxybenzamine—CALM1—forebrain—epilepsy syndrome	0.00041	0.0111	CbGeAlD
Phenoxybenzamine—Tachycardia—Felbamate—epilepsy syndrome	0.000405	0.00599	CcSEcCtD
Phenoxybenzamine—Fatigue—Midazolam—epilepsy syndrome	0.000405	0.00597	CcSEcCtD
Phenoxybenzamine—ADRA1A—brainstem—epilepsy syndrome	0.0004	0.0109	CbGeAlD
Phenoxybenzamine—Fatigue—Levetiracetam—epilepsy syndrome	0.000399	0.0059	CcSEcCtD
Phenoxybenzamine—Somnolence—Fosphenytoin—epilepsy syndrome	0.000398	0.00587	CcSEcCtD
Phenoxybenzamine—Tachycardia—Zonisamide—epilepsy syndrome	0.000397	0.00586	CcSEcCtD
Phenoxybenzamine—ADRA1B—head—epilepsy syndrome	0.000393	0.0107	CbGeAlD
Phenoxybenzamine—Somnolence—Vigabatrin—epilepsy syndrome	0.000387	0.00572	CcSEcCtD
Phenoxybenzamine—ADRA1A—forebrain—epilepsy syndrome	0.000386	0.0105	CbGeAlD
Phenoxybenzamine—ADRA1D—head—epilepsy syndrome	0.000385	0.0104	CbGeAlD
Phenoxybenzamine—Tachycardia—Clonazepam—epilepsy syndrome	0.000382	0.00565	CcSEcCtD
Phenoxybenzamine—Somnolence—Diazepam—epilepsy syndrome	0.000381	0.00563	CcSEcCtD
Phenoxybenzamine—Tachycardia—Phenytoin—epilepsy syndrome	0.00038	0.00561	CcSEcCtD
Phenoxybenzamine—CALM3—medulla oblongata—epilepsy syndrome	0.000379	0.0103	CbGeAlD
Phenoxybenzamine—CALM2—telencephalon—epilepsy syndrome	0.000379	0.0103	CbGeAlD
Phenoxybenzamine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000378	0.00558	CcSEcCtD
Phenoxybenzamine—CALM1—telencephalon—epilepsy syndrome	0.000377	0.0102	CbGeAlD
Phenoxybenzamine—Fatigue—Vigabatrin—epilepsy syndrome	0.000376	0.00555	CcSEcCtD
Phenoxybenzamine—ADRA1B—nervous system—epilepsy syndrome	0.000373	0.0101	CbGeAlD
Phenoxybenzamine—Drowsiness—Gabapentin—epilepsy syndrome	0.000371	0.00548	CcSEcCtD
Phenoxybenzamine—Asthenia—Acetazolamide—epilepsy syndrome	0.00037	0.00547	CcSEcCtD
Phenoxybenzamine—Fatigue—Diazepam—epilepsy syndrome	0.00037	0.00546	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.00037	0.00546	CcSEcCtD
Phenoxybenzamine—Somnolence—Felbamate—epilepsy syndrome	0.000369	0.00545	CcSEcCtD
Phenoxybenzamine—ADRA1D—nervous system—epilepsy syndrome	0.000365	0.0099	CbGeAlD
Phenoxybenzamine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000363	0.00536	CcSEcCtD
Phenoxybenzamine—Somnolence—Zonisamide—epilepsy syndrome	0.000361	0.00534	CcSEcCtD
Phenoxybenzamine—ADRA1B—central nervous system—epilepsy syndrome	0.000359	0.00975	CbGeAlD
Phenoxybenzamine—Fatigue—Felbamate—epilepsy syndrome	0.000358	0.00529	CcSEcCtD
Phenoxybenzamine—ADRA1A—telencephalon—epilepsy syndrome	0.000355	0.00963	CbGeAlD
Phenoxybenzamine—ADRA1D—central nervous system—epilepsy syndrome	0.000351	0.00953	CbGeAlD
Phenoxybenzamine—Fatigue—Zonisamide—epilepsy syndrome	0.00035	0.00518	CcSEcCtD
Phenoxybenzamine—Tachycardia—Lamotrigine—epilepsy syndrome	0.00035	0.00518	CcSEcCtD
Phenoxybenzamine—Somnolence—Clonazepam—epilepsy syndrome	0.000348	0.00514	CcSEcCtD
Phenoxybenzamine—CALM3—midbrain—epilepsy syndrome	0.000346	0.00939	CbGeAlD
Phenoxybenzamine—Somnolence—Phenytoin—epilepsy syndrome	0.000346	0.00511	CcSEcCtD
Phenoxybenzamine—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000344	0.00508	CcSEcCtD
Phenoxybenzamine—Asthenia—Propofol—epilepsy syndrome	0.000344	0.00508	CcSEcCtD
Phenoxybenzamine—ADRA2C—telencephalon—epilepsy syndrome	0.000338	0.00918	CbGeAlD
Phenoxybenzamine—Fatigue—Clonazepam—epilepsy syndrome	0.000338	0.00499	CcSEcCtD
Phenoxybenzamine—CALM3—spinal cord—epilepsy syndrome	0.000338	0.00916	CbGeAlD
Phenoxybenzamine—Asthenia—Midazolam—epilepsy syndrome	0.000337	0.00497	CcSEcCtD
Phenoxybenzamine—Fatigue—Phenytoin—epilepsy syndrome	0.000336	0.00496	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Topiramate—epilepsy syndrome	0.000335	0.00495	CcSEcCtD
Phenoxybenzamine—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000334	0.00493	CcSEcCtD
Phenoxybenzamine—Asthenia—Levetiracetam—epilepsy syndrome	0.000332	0.00491	CcSEcCtD
Phenoxybenzamine—Somnolence—Carbamazepine—epilepsy syndrome	0.00033	0.00488	CcSEcCtD
Phenoxybenzamine—Asthenia—Fosphenytoin—epilepsy syndrome	0.000321	0.00474	CcSEcCtD
Phenoxybenzamine—Fatigue—Carbamazepine—epilepsy syndrome	0.00032	0.00473	CcSEcCtD
Phenoxybenzamine—Somnolence—Lamotrigine—epilepsy syndrome	0.000319	0.00471	CcSEcCtD
Phenoxybenzamine—Asthenia—Vigabatrin—epilepsy syndrome	0.000313	0.00462	CcSEcCtD
Phenoxybenzamine—Fatigue—Lamotrigine—epilepsy syndrome	0.00031	0.00457	CcSEcCtD
Phenoxybenzamine—Bepridil—CACNA2D2—epilepsy syndrome	0.000309	0.0776	CrCbGaD
Phenoxybenzamine—Asthenia—Diazepam—epilepsy syndrome	0.000308	0.00455	CcSEcCtD
Phenoxybenzamine—Asthenia—Felbamate—epilepsy syndrome	0.000298	0.0044	CcSEcCtD
Phenoxybenzamine—CALM2—medulla oblongata—epilepsy syndrome	0.000297	0.00807	CbGeAlD
Phenoxybenzamine—CALM1—medulla oblongata—epilepsy syndrome	0.000296	0.00803	CbGeAlD
Phenoxybenzamine—ADRA2A—forebrain—epilepsy syndrome	0.000294	0.00797	CbGeAlD
Phenoxybenzamine—Bepridil—CACNA1A—epilepsy syndrome	0.000293	0.0735	CrCbGaD
Phenoxybenzamine—Asthenia—Zonisamide—epilepsy syndrome	0.000292	0.00431	CcSEcCtD
Phenoxybenzamine—SLC22A1—head—epilepsy syndrome	0.00029	0.00788	CbGeAlD
Phenoxybenzamine—ADRA1B—brain—epilepsy syndrome	0.000285	0.00774	CbGeAlD
Phenoxybenzamine—Asthenia—Clonazepam—epilepsy syndrome	0.000281	0.00415	CcSEcCtD
Phenoxybenzamine—Asthenia—Phenytoin—epilepsy syndrome	0.000279	0.00412	CcSEcCtD
Phenoxybenzamine—ADRA1D—brain—epilepsy syndrome	0.000279	0.00757	CbGeAlD
Phenoxybenzamine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000278	0.00411	CcSEcCtD
Phenoxybenzamine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000278	0.0041	CcSEcCtD
Phenoxybenzamine—SLC22A3—head—epilepsy syndrome	0.000278	0.00753	CbGeAlD
Phenoxybenzamine—SLC22A1—nervous system—epilepsy syndrome	0.000275	0.00747	CbGeAlD
Phenoxybenzamine—CALM2—midbrain—epilepsy syndrome	0.000272	0.00738	CbGeAlD
Phenoxybenzamine—CALM1—midbrain—epilepsy syndrome	0.000271	0.00734	CbGeAlD
Phenoxybenzamine—ADRA2A—telencephalon—epilepsy syndrome	0.00027	0.00732	CbGeAlD
Phenoxybenzamine—CALM3—cerebellum—epilepsy syndrome	0.000268	0.00727	CbGeAlD
Phenoxybenzamine—Asthenia—Carbamazepine—epilepsy syndrome	0.000267	0.00394	CcSEcCtD
Phenoxybenzamine—ADRA2C—medulla oblongata—epilepsy syndrome	0.000266	0.00721	CbGeAlD
Phenoxybenzamine—CALM2—spinal cord—epilepsy syndrome	0.000265	0.0072	CbGeAlD
Phenoxybenzamine—SLC22A1—central nervous system—epilepsy syndrome	0.000265	0.00719	CbGeAlD
Phenoxybenzamine—CALM1—spinal cord—epilepsy syndrome	0.000264	0.00716	CbGeAlD
Phenoxybenzamine—SLC22A3—nervous system—epilepsy syndrome	0.000263	0.00714	CbGeAlD
Phenoxybenzamine—Asthenia—Lamotrigine—epilepsy syndrome	0.000258	0.0038	CcSEcCtD
Phenoxybenzamine—Somnolence—Valproic Acid—epilepsy syndrome	0.000254	0.00375	CcSEcCtD
Phenoxybenzamine—SLC22A3—central nervous system—epilepsy syndrome	0.000253	0.00687	CbGeAlD
Phenoxybenzamine—Tachycardia—Pregabalin—epilepsy syndrome	0.000252	0.00372	CcSEcCtD
Phenoxybenzamine—Fatigue—Valproic Acid—epilepsy syndrome	0.000246	0.00363	CcSEcCtD
Phenoxybenzamine—ADRA2C—midbrain—epilepsy syndrome	0.000243	0.00659	CbGeAlD
Phenoxybenzamine—ADRA2C—spinal cord—epilepsy syndrome	0.000237	0.00643	CbGeAlD
Phenoxybenzamine—CALM2—head—epilepsy syndrome	0.000236	0.0064	CbGeAlD
Phenoxybenzamine—CALM1—head—epilepsy syndrome	0.000235	0.00637	CbGeAlD
Phenoxybenzamine—Tachycardia—Gabapentin—epilepsy syndrome	0.000231	0.00341	CcSEcCtD
Phenoxybenzamine—Somnolence—Pregabalin—epilepsy syndrome	0.000229	0.00339	CcSEcCtD
Phenoxybenzamine—CALM2—nervous system—epilepsy syndrome	0.000223	0.00606	CbGeAlD
Phenoxybenzamine—CALM1—nervous system—epilepsy syndrome	0.000222	0.00604	CbGeAlD
Phenoxybenzamine—Fatigue—Pregabalin—epilepsy syndrome	0.000222	0.00328	CcSEcCtD
Phenoxybenzamine—ADRA1A—head—epilepsy syndrome	0.000221	0.006	CbGeAlD
Phenoxybenzamine—CALM3—brain—epilepsy syndrome	0.000217	0.0059	CbGeAlD
Phenoxybenzamine—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000216	0.0543	CrCbGaD
Phenoxybenzamine—CALM2—central nervous system—epilepsy syndrome	0.000215	0.00584	CbGeAlD
Phenoxybenzamine—CALM1—central nervous system—epilepsy syndrome	0.000214	0.00581	CbGeAlD
Phenoxybenzamine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000212	0.00575	CbGeAlD
Phenoxybenzamine—ADRA2C—head—epilepsy syndrome	0.000211	0.00572	CbGeAlD
Phenoxybenzamine—SLC22A1—brain—epilepsy syndrome	0.00021	0.00571	CbGeAlD
Phenoxybenzamine—CALM2—cerebellum—epilepsy syndrome	0.00021	0.00571	CbGeAlD
Phenoxybenzamine—Somnolence—Gabapentin—epilepsy syndrome	0.00021	0.00311	CcSEcCtD
Phenoxybenzamine—ADRA1A—nervous system—epilepsy syndrome	0.00021	0.00569	CbGeAlD
Phenoxybenzamine—CALM1—cerebellum—epilepsy syndrome	0.000209	0.00568	CbGeAlD
Phenoxybenzamine—Asthenia—Valproic Acid—epilepsy syndrome	0.000205	0.00302	CcSEcCtD
Phenoxybenzamine—Fatigue—Gabapentin—epilepsy syndrome	0.000204	0.00301	CcSEcCtD
Phenoxybenzamine—ADRA1A—central nervous system—epilepsy syndrome	0.000202	0.00548	CbGeAlD
Phenoxybenzamine—SLC22A3—brain—epilepsy syndrome	0.000201	0.00546	CbGeAlD
Phenoxybenzamine—ADRA2C—nervous system—epilepsy syndrome	0.0002	0.00542	CbGeAlD
Phenoxybenzamine—ADRA1A—cerebellum—epilepsy syndrome	0.000197	0.00535	CbGeAlD
Phenoxybenzamine—Tachycardia—Topiramate—epilepsy syndrome	0.000194	0.00287	CcSEcCtD
Phenoxybenzamine—ADRA2A—midbrain—epilepsy syndrome	0.000194	0.00526	CbGeAlD
Phenoxybenzamine—ADRA2C—central nervous system—epilepsy syndrome	0.000192	0.00522	CbGeAlD
Phenoxybenzamine—ADRA2A—spinal cord—epilepsy syndrome	0.000189	0.00513	CbGeAlD
Phenoxybenzamine—ADRA2C—cerebellum—epilepsy syndrome	0.000188	0.0051	CbGeAlD
Phenoxybenzamine—Asthenia—Pregabalin—epilepsy syndrome	0.000185	0.00273	CcSEcCtD
Phenoxybenzamine—Bepridil—CACNA1H—epilepsy syndrome	0.000183	0.0459	CrCbGaD
Phenoxybenzamine—Somnolence—Topiramate—epilepsy syndrome	0.000177	0.00261	CcSEcCtD
Phenoxybenzamine—Bepridil—CACNA1D—epilepsy syndrome	0.000173	0.0433	CrCbGaD
Phenoxybenzamine—Fatigue—Topiramate—epilepsy syndrome	0.000172	0.00253	CcSEcCtD
Phenoxybenzamine—CALM2—brain—epilepsy syndrome	0.000171	0.00463	CbGeAlD
Phenoxybenzamine—CALM1—brain—epilepsy syndrome	0.00017	0.00461	CbGeAlD
Phenoxybenzamine—Asthenia—Gabapentin—epilepsy syndrome	0.00017	0.00251	CcSEcCtD
Phenoxybenzamine—Isopropamide—CHRM3—epilepsy syndrome	0.000169	0.0425	CrCbGaD
Phenoxybenzamine—ADRA2A—head—epilepsy syndrome	0.000168	0.00456	CbGeAlD
Phenoxybenzamine—Clomifene—CYP11A1—epilepsy syndrome	0.000165	0.0413	CrCbGaD
Phenoxybenzamine—ADRA1A—brain—epilepsy syndrome	0.00016	0.00435	CbGeAlD
Phenoxybenzamine—ADRA2A—nervous system—epilepsy syndrome	0.000159	0.00432	CbGeAlD
Phenoxybenzamine—Isopropamide—CHRM1—epilepsy syndrome	0.000158	0.0396	CrCbGaD
Phenoxybenzamine—ADRA2A—central nervous system—epilepsy syndrome	0.000153	0.00416	CbGeAlD
Phenoxybenzamine—ADRA2C—brain—epilepsy syndrome	0.000153	0.00414	CbGeAlD
Phenoxybenzamine—ADRA2A—cerebellum—epilepsy syndrome	0.00015	0.00407	CbGeAlD
Phenoxybenzamine—Asthenia—Topiramate—epilepsy syndrome	0.000143	0.00211	CcSEcCtD
Phenoxybenzamine—Orphenadrine—SCN9A—epilepsy syndrome	0.000134	0.0336	CrCbGaD
Phenoxybenzamine—CYP3A4—nervous system—epilepsy syndrome	0.000125	0.0034	CbGeAlD
Phenoxybenzamine—Orphenadrine—SCN4A—epilepsy syndrome	0.000123	0.0309	CrCbGaD
Phenoxybenzamine—ADRA2A—brain—epilepsy syndrome	0.000122	0.00331	CbGeAlD
Phenoxybenzamine—CYP3A4—central nervous system—epilepsy syndrome	0.000121	0.00328	CbGeAlD
Phenoxybenzamine—Ethopropazine—CHRM1—epilepsy syndrome	0.000114	0.0286	CrCbGaD
Phenoxybenzamine—Dextropropoxyphene—OPRD1—epilepsy syndrome	0.000106	0.0267	CrCbGaD
Phenoxybenzamine—Fentanyl—OPRD1—epilepsy syndrome	0.000105	0.0264	CrCbGaD
Phenoxybenzamine—Levomethadyl Acetate—OPRM1—epilepsy syndrome	9.42e-05	0.0236	CrCbGaD
Phenoxybenzamine—Ethopropazine—CHRM2—epilepsy syndrome	9.3e-05	0.0233	CrCbGaD
Phenoxybenzamine—Orphenadrine—SCN1A—epilepsy syndrome	8.99e-05	0.0226	CrCbGaD
Phenoxybenzamine—Ospemifene—CYP2C19—epilepsy syndrome	8.93e-05	0.0224	CrCbGaD
Phenoxybenzamine—Dextropropoxyphene—OPRM1—epilepsy syndrome	8.14e-05	0.0204	CrCbGaD
Phenoxybenzamine—Fentanyl—OPRM1—epilepsy syndrome	8.05e-05	0.0202	CrCbGaD
Phenoxybenzamine—Ethopropazine—BCHE—epilepsy syndrome	7.75e-05	0.0195	CrCbGaD
Phenoxybenzamine—Methadone—OPRD1—epilepsy syndrome	7.21e-05	0.0181	CrCbGaD
Phenoxybenzamine—Tripelennamine—CYP2D6—epilepsy syndrome	5.61e-05	0.0141	CrCbGaD
Phenoxybenzamine—Methadone—OPRM1—epilepsy syndrome	5.52e-05	0.0139	CrCbGaD
Phenoxybenzamine—Benzphetamine—ADRA2A—epilepsy syndrome	5.15e-05	0.0129	CrCbGaD
Phenoxybenzamine—Diphenhydramine—CHRM2—epilepsy syndrome	4.84e-05	0.0121	CrCbGaD
Phenoxybenzamine—Orphenadrine—CHRM2—epilepsy syndrome	4.58e-05	0.0115	CrCbGaD
Phenoxybenzamine—Modafinil—CYP2C19—epilepsy syndrome	4.3e-05	0.0108	CrCbGaD
Phenoxybenzamine—Fenoprofen—PTGS2—epilepsy syndrome	4.27e-05	0.0107	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCC2—epilepsy syndrome	4.18e-05	0.0105	CrCbGaD
Phenoxybenzamine—Atomoxetine—SLC6A4—epilepsy syndrome	3.9e-05	0.00979	CrCbGaD
Phenoxybenzamine—Toremifene—ABCB1—epilepsy syndrome	3.85e-05	0.00967	CrCbGaD
Phenoxybenzamine—Fenoprofen—ALB—epilepsy syndrome	3.81e-05	0.00955	CrCbGaD
Phenoxybenzamine—Propafenone—CYP2D6—epilepsy syndrome	3.8e-05	0.00954	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCG2—epilepsy syndrome	3.7e-05	0.00928	CrCbGaD
Phenoxybenzamine—Atomoxetine—CYP2C19—epilepsy syndrome	3.7e-05	0.00928	CrCbGaD
Phenoxybenzamine—Phenylbutazone—PTGS2—epilepsy syndrome	3.42e-05	0.00857	CrCbGaD
Phenoxybenzamine—Bepridil—CYP2D6—epilepsy syndrome	3.39e-05	0.0085	CrCbGaD
Phenoxybenzamine—Clomifene—ABCB1—epilepsy syndrome	3.33e-05	0.00836	CrCbGaD
Phenoxybenzamine—Dextropropoxyphene—CYP2D6—epilepsy syndrome	3.15e-05	0.00791	CrCbGaD
Phenoxybenzamine—Atomoxetine—HTR2A—epilepsy syndrome	3e-05	0.00752	CrCbGaD
Phenoxybenzamine—Diphenhydramine—CYP2C19—epilepsy syndrome	2.99e-05	0.00749	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP2C19—epilepsy syndrome	2.91e-05	0.0073	CrCbGaD
Phenoxybenzamine—Methadone—CYP2C19—epilepsy syndrome	2.88e-05	0.00723	CrCbGaD
Phenoxybenzamine—Atomoxetine—CYP2D6—epilepsy syndrome	2.74e-05	0.00688	CrCbGaD
Phenoxybenzamine—Propafenone—ABCB1—epilepsy syndrome	2.72e-05	0.00681	CrCbGaD
Phenoxybenzamine—Bepridil—ABCB1—epilepsy syndrome	2.42e-05	0.00607	CrCbGaD
Phenoxybenzamine—Fentanyl—ABCB1—epilepsy syndrome	2.23e-05	0.00558	CrCbGaD
Phenoxybenzamine—Diphenhydramine—CYP2D6—epilepsy syndrome	2.21e-05	0.00555	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP2D6—epilepsy syndrome	2.16e-05	0.00541	CrCbGaD
Phenoxybenzamine—Methadone—CYP2D6—epilepsy syndrome	2.14e-05	0.00536	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCB1—epilepsy syndrome	1.54e-05	0.00386	CrCbGaD
Phenoxybenzamine—Methadone—ABCB1—epilepsy syndrome	1.53e-05	0.00383	CrCbGaD
Phenoxybenzamine—CALM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.53e-06	1.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MEF2C—epilepsy syndrome	1.52e-06	1.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.52e-06	1.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.52e-06	1.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.52e-06	1.27e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.51e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—FGF2—epilepsy syndrome	1.51e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—FGF2—epilepsy syndrome	1.51e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.51e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NGF—epilepsy syndrome	1.5e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.5e-06	1.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.5e-06	1.25e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.49e-06	1.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.49e-06	1.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.49e-06	1.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.49e-06	1.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—BCL2—epilepsy syndrome	1.49e-06	1.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.48e-06	1.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.48e-06	1.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.48e-06	1.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.47e-06	1.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.47e-06	1.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.47e-06	1.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.47e-06	1.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCR5—epilepsy syndrome	1.46e-06	1.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.46e-06	1.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.46e-06	1.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NGF—epilepsy syndrome	1.46e-06	1.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NGF—epilepsy syndrome	1.46e-06	1.22e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.45e-06	1.21e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—RELA—epilepsy syndrome	1.45e-06	1.21e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.44e-06	1.21e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—FGF2—epilepsy syndrome	1.44e-06	1.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	1.44e-06	1.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—BCL2—epilepsy syndrome	1.44e-06	1.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—BCL2—epilepsy syndrome	1.44e-06	1.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HTR2A—epilepsy syndrome	1.43e-06	1.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.43e-06	1.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MTOR—epilepsy syndrome	1.42e-06	1.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCR5—epilepsy syndrome	1.42e-06	1.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCR5—epilepsy syndrome	1.42e-06	1.18e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.41e-06	1.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—RELA—epilepsy syndrome	1.4e-06	1.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—RELA—epilepsy syndrome	1.4e-06	1.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—FGF2—epilepsy syndrome	1.4e-06	1.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—FGF2—epilepsy syndrome	1.4e-06	1.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.39e-06	1.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HTR2A—epilepsy syndrome	1.39e-06	1.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MTOR—epilepsy syndrome	1.38e-06	1.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MTOR—epilepsy syndrome	1.38e-06	1.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.38e-06	1.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.37e-06	1.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—POMC—epilepsy syndrome	1.37e-06	1.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.37e-06	1.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.37e-06	1.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	1.36e-06	1.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TSC2—epilepsy syndrome	1.36e-06	1.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AGT—epilepsy syndrome	1.36e-06	1.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.36e-06	1.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	1.36e-06	1.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—AKT1—epilepsy syndrome	1.35e-06	1.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.35e-06	1.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.34e-06	1.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	1.34e-06	1.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—APOE—epilepsy syndrome	1.33e-06	1.11e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.33e-06	1.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—POMC—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—POMC—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TSC2—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TSC2—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MTOR—epilepsy syndrome	1.32e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AGT—epilepsy syndrome	1.31e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AGT—epilepsy syndrome	1.31e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1B—epilepsy syndrome	1.31e-06	1.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—AKT1—epilepsy syndrome	1.31e-06	1.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—AKT1—epilepsy syndrome	1.31e-06	1.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KDR—epilepsy syndrome	1.3e-06	1.09e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.3e-06	1.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTGS2—epilepsy syndrome	1.3e-06	1.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOE—epilepsy syndrome	1.29e-06	1.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOE—epilepsy syndrome	1.29e-06	1.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.28e-06	1.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—JUN—epilepsy syndrome	1.27e-06	1.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MTOR—epilepsy syndrome	1.27e-06	1.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MTOR—epilepsy syndrome	1.27e-06	1.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—epilepsy syndrome	1.27e-06	1.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—epilepsy syndrome	1.27e-06	1.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1.27e-06	1.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KDR—epilepsy syndrome	1.26e-06	1.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KDR—epilepsy syndrome	1.26e-06	1.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—epilepsy syndrome	1.26e-06	1.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—epilepsy syndrome	1.26e-06	1.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PRKCB—epilepsy syndrome	1.26e-06	1.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.25e-06	1.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6ST—epilepsy syndrome	1.25e-06	1.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ALB—epilepsy syndrome	1.25e-06	1.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.25e-06	1.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	1.24e-06	1.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.24e-06	1.04e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.24e-06	1.04e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.24e-06	1.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.23e-06	1.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—JUN—epilepsy syndrome	1.23e-06	1.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—JUN—epilepsy syndrome	1.23e-06	1.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.23e-06	1.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.22e-06	1.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.22e-06	1.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.22e-06	1.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—AKT1—epilepsy syndrome	1.22e-06	1.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PRKCB—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—AKT1—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6ST—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.2e-06	9.98e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.19e-06	9.96e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.19e-06	9.92e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.18e-06	9.86e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.18e-06	9.84e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—AKT1—epilepsy syndrome	1.18e-06	9.83e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—AKT1—epilepsy syndrome	1.18e-06	9.83e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	1.17e-06	9.79e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—AKT1—epilepsy syndrome	1.17e-06	9.76e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.17e-06	9.74e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.16e-06	9.7e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.16e-06	9.65e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.15e-06	9.63e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.15e-06	9.6e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—POMC—epilepsy syndrome	1.14e-06	9.55e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	1.14e-06	9.54e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-06	9.53e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—SRC—epilepsy syndrome	1.14e-06	9.53e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.14e-06	9.48e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—AKT1—epilepsy syndrome	1.13e-06	9.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—AKT1—epilepsy syndrome	1.13e-06	9.44e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.12e-06	9.39e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.12e-06	9.36e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—epilepsy syndrome	1.12e-06	9.34e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	1.11e-06	9.27e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.11e-06	9.26e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.11e-06	9.25e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-06	9.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—POMC—epilepsy syndrome	1.11e-06	9.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—POMC—epilepsy syndrome	1.11e-06	9.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—SRC—epilepsy syndrome	1.1e-06	9.22e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—SRC—epilepsy syndrome	1.1e-06	9.22e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.09e-06	9.12e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	9.11e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.09e-06	9.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—epilepsy syndrome	1.08e-06	9.04e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—epilepsy syndrome	1.08e-06	9.04e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	1.08e-06	9.02e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.07e-06	8.9e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.06e-06	8.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	8.81e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	8.81e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—SRC—epilepsy syndrome	1.05e-06	8.8e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	1.05e-06	8.79e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.05e-06	8.74e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.04e-06	8.67e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.03e-06	8.61e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.03e-06	8.59e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	1.02e-06	8.56e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—SRC—epilepsy syndrome	1.02e-06	8.51e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—SRC—epilepsy syndrome	1.02e-06	8.51e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-06	8.44e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-06	8.43e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.01e-06	8.42e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	9.99e-07	8.34e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	9.96e-07	8.31e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	9.8e-07	8.18e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FGF2—epilepsy syndrome	9.79e-07	8.17e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FGF2—epilepsy syndrome	9.79e-07	8.17e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	9.7e-07	8.1e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.7e-07	8.1e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	9.7e-07	8.1e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.57e-07	7.99e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	9.54e-07	7.97e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	9.44e-07	7.88e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RELA—epilepsy syndrome	9.39e-07	7.84e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.37e-07	7.82e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.31e-07	7.77e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	9.28e-07	7.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MTOR—epilepsy syndrome	9.21e-07	7.69e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	9.16e-07	7.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RELA—epilepsy syndrome	9.08e-07	7.58e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RELA—epilepsy syndrome	9.08e-07	7.58e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	9.02e-07	7.53e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MTOR—epilepsy syndrome	8.91e-07	7.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MTOR—epilepsy syndrome	8.91e-07	7.44e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	8.77e-07	7.32e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	8.7e-07	7.27e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.65e-07	7.23e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	8.51e-07	7.1e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	8.48e-07	7.08e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CASP3—epilepsy syndrome	8.47e-07	7.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—JUN—epilepsy syndrome	8.23e-07	6.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CASP3—epilepsy syndrome	8.19e-07	6.84e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CASP3—epilepsy syndrome	8.19e-07	6.84e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	8.09e-07	6.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—epilepsy syndrome	8e-07	6.68e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—JUN—epilepsy syndrome	7.96e-07	6.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—JUN—epilepsy syndrome	7.96e-07	6.64e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.88e-07	6.58e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—epilepsy syndrome	7.76e-07	6.48e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—epilepsy syndrome	7.74e-07	6.46e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—epilepsy syndrome	7.74e-07	6.46e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	7.61e-07	6.35e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.59e-07	6.34e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—epilepsy syndrome	7.51e-07	6.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—epilepsy syndrome	7.51e-07	6.27e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.44e-07	6.21e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	7.4e-07	6.18e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SRC—epilepsy syndrome	7.38e-07	6.16e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	7.34e-07	6.13e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—epilepsy syndrome	7.19e-07	6e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SRC—epilepsy syndrome	7.14e-07	5.96e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SRC—epilepsy syndrome	7.14e-07	5.96e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—epilepsy syndrome	7.09e-07	5.92e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—epilepsy syndrome	7.09e-07	5.92e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—epilepsy syndrome	6.95e-07	5.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—epilepsy syndrome	6.95e-07	5.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—epilepsy syndrome	6.86e-07	5.73e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—epilepsy syndrome	6.86e-07	5.73e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	6.62e-07	5.53e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—epilepsy syndrome	6.55e-07	5.47e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	6.54e-07	5.46e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.39e-07	5.33e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—epilepsy syndrome	6.33e-07	5.29e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—epilepsy syndrome	6.33e-07	5.29e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	6.19e-07	5.17e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	6.09e-07	5.08e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	6.01e-07	5.02e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.82e-07	4.86e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—epilepsy syndrome	5.48e-07	4.58e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	5.41e-07	4.52e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—epilepsy syndrome	5.31e-07	4.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—epilepsy syndrome	5.31e-07	4.43e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.1e-07	4.25e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	5.03e-07	4.2e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—epilepsy syndrome	4.59e-07	3.83e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—epilepsy syndrome	4.44e-07	3.7e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—epilepsy syndrome	4.44e-07	3.7e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.56e-07	2.14e-06	CbGpPWpGaD
